Fatemeh Keshavarz, Mohsen Soltanshahi, Malaksima Ayadilord, Faezeh Mortazavi, Mahdi Shabani, Seyed Amir Jalali. Multi-tyrosine kinase inhibitors: exploring immunomodulatory effects on various immune cell types in cancer. // Cancer Cell International. – 2026. – DOI: 10.1186/s12935-025-04141-x. – URL: https://doi.org/10.1186/s12935-025-04141-x
Fatemeh Keshavarz, Mohsen Soltanshahi, Malaksima Ayadilord, Faezeh Mortazavi, Mahdi Shabani, & Seyed Amir Jalali (2026). Multi-tyrosine kinase inhibitors: exploring immunomodulatory effects on various immune cell types in cancer. Cancer Cell International. https://doi.org/10.1186/s12935-025-04141-x
Fatemeh Keshavarz, et al. “Multi-tyrosine kinase inhibitors: exploring immunomodulatory effects on various immune cell types in cancer.” Cancer Cell International, 2026. doi:10.1186/s12935-025-04141-x.
@article{Keshavarz2026,
title = {Multi-tyrosine kinase inhibitors: exploring immunomodulatory effects on various immune cell types in cancer},
author = {Keshavarz, Fatemeh and Soltanshahi, Mohsen and Ayadilord, Malaksima and Mortazavi, Faezeh and Shabani, Mahdi and Jalali, Seyed Amir},
journal = {Cancer Cell International},
year = {2026},
doi = {10.1186/s12935-025-04141-x},
url = {https://doi.org/10.1186/s12935-025-04141-x}
}